Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision identifier was updated from v3.6.2 to v3.6.3, signaling a new iteration of the page's backend release. This appears to be an internal update rather than a change to study details or displayed information.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, signaling a minor page update to the study record. It does not modify the study data, eligibility criteria, or results.SummaryDifference0.0%

- Check38 days agoChange DetectedThe study page now indicates recruitment has ended. New help sections—How to Read a Study Record, Common Questions, and How to Join a Study—provide added guidance for users navigating the page.SummaryDifference0.4%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a minor metadata update to the document version.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the site. This change does not appear to modify the study details or user-visible information.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page’s footer/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.